Books > Social sciences > Sociology, social studies > Social issues > Illness & addiction: social aspects > AIDS: social aspects
|
Not currently available
The Economics of Effective AIDS Treatment - Evaluating Policy Options for Thailand (Paperback)
Loot Price: R623
Discovery Miles 6 230
|
|
The Economics of Effective AIDS Treatment - Evaluating Policy Options for Thailand (Paperback)
Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.
|
HIV is the leading cause of premature death in Thailand. Since the
first case of AIDS was reported in 1984 more than one million Thais
have been infected. The social, human and economic costs of this
burden are enormous. The Thai government has shown a strong
commitment to providing care and support to persons living with
HIV/AIDS by launching the National Access to Care Program (NAPHA)
in 2003, which provides for publicly financed antiretroviral
therapy (ART) to all HIV-infected people. This book documents
through interviews how ART has radically changed the lives of those
living with HIV. In the words of an HIV positive 29-year old man,
ART is a 'miracle'. The book then develops an innovative analytical
framework and uses it to show how the future sustainability and
cost-effectiveness of this ambitious program depend critically on
Thai government choices of AIDS treatment policy, HIV prevention
policy and AIDS drug pricing. For the most likely assumptions, the
book estimates that ART will save years of healthy life at a cost
of between $700 and $2,400 per year. Successful AIDS treatment
accumulates ever-increasing numbers of patients who need subsidized
ART. Despite the magnitude of the resulting fiscal burden, the
authors judge this expenditure to be a worthwhile public health
investment for Thailand. However, they show that the future
sustainability of the program will hinge critically on how well the
government manages the quality of ART service delivery, on whether
it is able to sustain its past successes in HIV prevention and on
its negotiations with multinational pharmaceutical manufacturers on
the prices of new AIDS drugs.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.